The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Breast Cancer in Men
Abstract
Breast cancer in men accounts for about 1% of all breast cancers and is mainly estrogen-receptor–positive. Few prospective studies of treatment in men have been performed, so management is based largely on extrapolation from results in postmenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,579
Veronesi, U., Cascinelli, N., Mariani, L., Greco, M., Saccozzi, R., Luini, A., Aguilar, M., & Marubini, E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020989 · Cited by 4,450
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
Baselga, J., Campone, M., Piccart, M., Burris, H. A., Rugo, H. S., Sahmoud, T., Noguchi, S., Gnant, M., Pritchard, K. I., Lebrun, F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109653 · Cited by 2,863
Palbociclib in hormone-receptor-positive advanced breast cancer
Turner, N. C., Ro, J., André, F., Loi, S., Verma, S., Iwata, H., Harbeck, N., Loibl, S., Huang Bartlett, C., Zhang, K., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505270 · Cited by 1,590
The CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
The Breast Cancer Susceptibility Collaboration (UK), Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., et al. (2007) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,003
Breast carcinoma in men: A population‐based study
Giordano, S. H., Cohen, D. S., Buzdar, A. U., Perkins, G., & Hortobagyi, G. N. (2004) · Cancer · doi:10.1002/cncr.20312 · Cited by 789
Self-citationDiéras, V., Miles, D., Verma, S., Pegram, M., Welslau, M., Baselga, J., Krop, I. E., Blackwell, K., Hoersch, S., Xu, J., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30312-1 · Cited by 667
Krop, I. E., Kim, S.-B., Martin, A. G., LoRusso, P. M., Ferrero, J.-M., Badovinac-Crnjevic, T., Hoersch, S., Smitt, M., & Wildiers, H. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30313-3 · Cited by 531
Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer
Anderson, W. F., Jatoi, I., Tse, J., & Rosenberg, P. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.8162 · Cited by 495
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
Korde, L. A., Zujewski, J. A., Kamin, L., Giordano, S., Domchek, S., Anderson, W. F., Bartlett, J. M. S., Gelmon, K., Nahleh, Z., Bergh, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.5729 · Cited by 487
Self-citationA recurrent mutation in PALB2 in Finnish cancer families
Erkko, H., Xia, B., Nikkilä, J., Schleutker, J., Syrjäkoski, K., Mannermaa, A., Kallioniemi, A., Pylkäs, K., Karppinen, S.-M., Rapakko, K., et al. (2007) · Nature · doi:10.1038/nature05609 · Cited by 466
Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation Carriers
Tai, Y. C., Domchek, S., Parmigiani, G., & Chen, S. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm203 · Cited by 430
NCCN Task Force Report: Bone Health in Cancer Care
Gralow, J. R., Biermann, J. S., Farooki, A., Fornier, M. N., Gagel, R. F., Kumar, R., Litsas, G., McKay, R., Podoloff, D. A., Srinivas, S., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0215 · Cited by 412
Cardoso, F., Bartlett, J. M. S., Slaets, L., van Deurzen, C. H. M., van Leeuwen-Stok, E., Porter, P., Linderholm, B., Hedenfalk, I., Schröder, C., Martens, J., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx651 · Cited by 405
Self-citationSasco, A. J., Lowenfels, A. B., & Jong, P. C. M. P.-D. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530403 · Cited by 397
Bcl-2 protein expression and long-term survival in breast cancer.
Joensuu, H., Pylkkänen, L. H., & Toikkanen, S. (1994) · PubMed · Cited by 396
Vera-Badillo, F. E., Templeton, A. J., de Gouveia, P., Diaz-Padilla, I., Bedard, P. L., Al-Mubarak, M., Seruga, B., Tannock, I. F., Ocana, A., & Amir, E. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt319 · Cited by 370
Population-based study of risk of breast cancer in carriers of BRCA2 mutation
Thorlacius, S., Struewing, J. P., Hartage, P., Olafsdottir, G. H., Sigvaldason, H., Tryggvadottir, L., Wacholder, S., Tulinius, H., & Eyfjörd, J. E. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03300-5 · Cited by 348
Goss, P. E., Reid, C., Pintilie, M., Lim, R., & Miller, N. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<629::aid-cncr13>3.0.co;2-v · Cited by 325
Cancer Incidence and Mortality in Men with Klinefelter Syndrome: A Cohort Study
Swerdlow, A. J., Schoemaker, M. J., Higgins, C. D., Wright, A. F., & Jacobs, P. A. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji240 · Cited by 306
Incidence and Outcome of Male Breast Cancer: An International Population-Based Study
Miao, H., Verkooijen, H. M., Chia, K., Bouchardy, C., Pukkala, E., Larønningen, S., Mellemkjær, L., Czene, K., & Hartman, M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.8902 · Cited by 271
Arimidex�: A potent and selective fourth-generation aromatase inhibitor
Plourde, P. V., Dyroff, M., & Dukes, M. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00682745 · Cited by 258
Wooster, R., Mangion, J., Eeles, R., Smith, S., Dowsett, M., Averill, D., Barrett-Lee, P., Easton, D. F., Ponder, B. A. J., & Stratton, M. R. (1992) · Nature Genetics · doi:10.1038/ng1092-132 · Cited by 250
Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer
Casadei, S., Norquist, B. M., Walsh, T., Stray, S., Mandell, J. B., Lee, M. K., Stamatoyannopoulos, J. A., & King, M.-C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3958 · Cited by 240
Breast Cancer In Men: Risk Factors with Hormonal Implications
Thomas, D. B., Margarita Jimenez, L., McTieman, A., Rosenblatt, K., Stalsberg, H., Stemhagen, A., Douglas Thompson, W., McCrea Curnen, M. G., Satariano, W., Austin, D. F., et al. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116360 · Cited by 229
Prevalence of Klinefelter's syndrome in male breast cancer patients.
Hultborn, R., Hanson, C., Köpf, I., Verbiené, I., Warnhammar, E., & WEIMARCK, A. (1998) · PubMed · Cited by 218
BRCA1 and BRCA2 mutations in a population-based study of male breast cancer
Basham, V. M., Lipscombe, J. M., Ward, J. M., Gayther, S. A., Ponder, B. A., Easton, D. F., & Pharoah, P. D. (2001) · Breast Cancer Research · doi:10.1186/bcr419 · Cited by 191
Male breast cancer in Cowden syndrome patients with germline PTEN mutations
Fackenthal, J. D., Marsh, D. J., Richardson, A.-L., Cummings, S. A., Eng, C., Robinson, B. G., & Olopade, O. I. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.3.159 · Cited by 190
Frontometaphyseal dysplasia: Neonatal radiographic diagnosis
Glass, R. B. J., & Rosenbaum, K. N. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320570102 · Cited by 189
Jaiyesimi, I. A., Buzdar, A. U., Sahin, A. A., & Ross, M. A. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-9-771 · Cited by 185
Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.
Håkansson, S., Jóhannsson, Ó. Þ., Johansson, U., Sellberg, G., Loman, N., Gerdes, A., Holmberg, E., Dahl, N., Pandis, N., Kristoffersson, U., et al. (1997) · Europe PMC (PubMed Central) · Cited by 175
The Genomic Landscape of Male Breast Cancers
Piscuoglio, S., Ng, C. K. Y., Murray, M. P., Guerini‐Rocco, E., Martelotto, L. G., Geyer, F. C., Bidard, F., Berman, S., Fusco, N., Sakr, R. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2840 · Cited by 172
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
Eggemann, H., Ignatov, A., Smith, B. J., Altmann, U., von Minckwitz, G., Röhl, F. W., Jahn, M., & Costa, S.-D. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2355-3 · Cited by 164
Brinton, L. A., Cook, M. B., McCormack, V., Johnson, K. C., Olsson, H., Casagrande, J. T., Cooke, R., Falk, R. T., Gapstur, S. M., Gaudet, M. M., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt465 · Cited by 164
Prospective Evaluation of Risk Factors for Male Breast Cancer
Brinton, L. A., Richesson, D. A., Gierach, G. L., Lacey, J. V., Park, Y., Hollenbeck, A. R., & Schatzkin, A. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn329 · Cited by 160
Williams, M. J. (1963) · The American Journal of Medicine · doi:10.1016/0002-9343(63)90044-5 · Cited by 154
Irani, J., Salomon, L., Oba, R., Bouchard, P., & Mottet, N. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70338-9 · Cited by 153
Molecular markers in male breast carcinoma
Rayson, D., Erlichman, C., Suman, V. J., Roche, P. C., Wold, L. E., Ingle, J. N., & Donohue, J. H. (1998) · Cancer · Cited by 150
Risk Factors for Male Breast Cancer 2
Mabuchi, K., Bross, D., & Kessler, I. I. (1985) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/74.2.371 · Cited by 139
Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects
Pemmaraju, N., Munsell, M. F., Hortobágyi, G. N., & Giordano, S. H. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr459 · Cited by 133
Self-citationMutations in BRCA2 and PALB2 in male breast cancer cases from the United States
Ding, Y. C., Steele, L., Kuan, C.-J., Greilac, S., & Neuhausen, S. L. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1195-2 · Cited by 130
Johansson, I., Nilsson, C., Berglund, P., Lauss, M., Ringnér, M., Olsson, H. L., Luts, L., Sim, E., Thorstenson, S., Fjällskog, M.-L., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3116 · Cited by 127
Role of adjuvant chemotherapy in male breast cancer
Patel, H. Z., Buzdar, A. U., & Hortobágyi, G. N. (1989) · Cancer · Cited by 119
Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database
Brinton, L. A., Carreon, J. D., Gierach, G. L., McGlynn, K. A., & Gridley, G. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0379-0 · Cited by 118
Prognostic and Predictive Factors
Scott, M. T., & Hall, P. A. (2004) · Humana Press eBooks · doi:10.1385/1-59259-760-2:001 · Cited by 117
A comparison outcome of male breast cancer with female breast cancer
Willsher, P. C., LEACH, I. H., Ellis, I. O., Bourke, J. B., Blamey, R. W., & Robertson, J. F. R. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)89592-x · Cited by 115
Male breast cancer: a 22-year experience
Yıldırım, E., & Berberoğlu, U. (1998) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(98)93608-3 · Cited by 112
Risk of Breast Cancer in Men With Liver Cirrhosis
Sørensen, H. T., Friis, S., Olsen, J. H., Thulstrup, A. M., Mellemkjær, L., Linet, M. S., Trichopoulos, D., Vilstrup, H., & Olsen, J. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00231.x · Cited by 109
Orr, N., Lemnrau, A., Cooke, R., Fletcher, O., Tomczyk, K., Jones, M. E., Johnson, N., Lord, C. J., Mitsopoulos, C., Zvelebil, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2417 · Cited by 107
Male breast cancer: a 13-year review of 89 patients.
Erlichman, C., Murphy, K., & Elhakim, T. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.8.903 · Cited by 107
Carcinoma of the male breast: Analysis of prognosis compared with matched female patients
Borgen, P. I., Senie, R. T., McKINNON, W. M. P., & Rosen, P. P. (1997) · Annals of Surgical Oncology · doi:10.1007/bf02305550 · Cited by 98
Outcomes of Partial Mastectomy in Male Breast Cancer Patients: Analysis of SEER, 1983–2009
Cloyd, J. M., Hernandez‐Boussard, T., & Wapnir, I. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2918-5 · Cited by 97
A polymorphism in the CYP17 gene is associated with male breast cancer
Young, I., Kurian, K. M., Annink, C. E., Kunkler, I. H., Anderson, V. A., Cohen, B. B., Hooper, M. L., Wyllie, A. H., & Steel, C. M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690663 · Cited by 94
Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk
Brinton, L. A., Key, T., Kolonel, L. N., Michels, K. B., Sesso, H. D., Ursin, G., Eeden, S. K. V. D., Wood, S. N., Falk, R. T., Parisi, D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.1602 · Cited by 92
Aromatase inhibition in male breast cancer patients: biological and clinical implications
Doyen, J., Italiano, A., Largillier, R., Ferrero, J.-M., Fontana, X., & Thyss, A. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp450 · Cited by 87
Clinical correlations of steroid receptors and male breast cancer.
Everson, R. B., Lippman, M. E., Thompson, E. B., McGuire, W. L., Wittliff, J. L., Sombre, E. R. D., Jensen, E. V., Singhakowinta, A., Brooks, S., & Neifeld, J. P. (1980) · PubMed · Cited by 85
Sasano, H., Kimura, M., Shizawa, S., Kimura, N., & Nagura, H. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768875 · Cited by 83
Male Breast Cancer Incidence Among Atomic Bomb Survivors
Ron, E., Ikeda, T., Preston, D. L., & Tokuoka, S. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji097 · Cited by 82
Breast cancer in men in the United States
Harlan, L. C., Zujewski, J. A., Goodman, M. T., & Stevens, J. L. (2010) · Cancer · doi:10.1002/cncr.25153 · Cited by 79
Csókay, B., Udvarhelyi, N., Sulyok, Z., et al. (1999) · PubMed · Cited by 79
Cameron, D., Morden, J. P., Canney, P. A., Velikova, G., Coleman, R. E., Bartlett, J. M. S., Agrawal, R. K., Banerji, J., Bertelli, G., Bloomfield, D. J., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30404-7 · Cited by 72
Weber-Chappuis, K., Bieri-Burger, S., & HURLIMANN, J. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00154-2 · Cited by 67
Sandler, B., Carman, C., & Perry, R. R. (1994) · PubMed · Cited by 67
Male Breast Carcinoma: Review of a Multicenter Series of 150 Cases
Ciatto, S., Iossa, A., Bonardi, R., Pacini, P., Berardi, T., Leo, G. D., Punzo, C., Amadori, D., Barni, S., Rulli, A., et al. (1990) · Tumori Journal · doi:10.1177/030089169007600608 · Cited by 67
Ionizing radiation and breast cancer in men (United States)
Thomas, D. B., Rosenblatt, K. A., Jimenez, L. M., et al. (1994) · Cancer Causes & Control · doi:10.1007/bf01830721 · Cited by 65
CHEK2 1100delC is not a risk factor for male breast cancer population
Syrjäkoski, K., Kuukasjärvi, T., Auvinen, A. P., & Kallioniemi, O. (2003) · International Journal of Cancer · doi:10.1002/ijc.11384 · Cited by 63
Is Breast Conserving Therapy a Safe Modality for Early-Stage Male Breast Cancer?
Zaenger, D., Rabatic, B. M., Dasher, B. G., & Mourad, W. F. (2015) · Clinical Breast Cancer · doi:10.1016/j.clbc.2015.11.005 · Cited by 61
CHEK2 1100delC and male breast cancer in the Netherlands
Wasielewski, M., den Bakker, M. A., van den Ouweland, A., Gelder, M. E. M., Portengen, H., Klijn, J. G. M., Meijers-Heijboer, H. E. J., Foekens, J. A., & Schutte, M. E. M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0162-7 · Cited by 57
Hormonal Treatment of Disseminated Male Breast Cancer
Lopez, M., Lauro, L. D., Lazzaro, B., & Papaldo, P. (2009) · Oncology · doi:10.1159/000226061 · Cited by 57
Blanco, A., de la Hoya, M., Balmañà, J., y Cajal, T. R., Teulé, À., Miramar, M.-D., Esteban, E., Infante, M., Benitez, J. J., Torres, A., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1842-2 · Cited by 57
The Landscape of Candidate Driver Genes Differs between Male and Female Breast Cancer
Johansson, I., Ringnér, M., & Hedenfalk, I. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078299 · Cited by 56
Zagouri, F., Sergentanis, T. Ν., Koutoulidis, V., Sparber, C., Steger, G. G., Dubsky, P. C., Zografos, G. C., Ψαλτοπούλου, Θ., Gnant, M., Dimopoulos, M. A., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.255 · Cited by 55
PALB2 analysis in BRCA2-like families
Adank, M. A., van Mil, S. E., Gille, J. J. P., Waisfisz, Q., & Meijers-Heijboer, H. E. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1001-1 · Cited by 53
Role of CHEK2*1100delC in unselected series of non‐BRCA1/2 male breast cancers
Neuhausen, S. L., Dunning, A. M., Steele, L., Yakumo, K., Hoffman, M. D., Szabo, C., Tee, L. J., Baines, C., Pharoah, P. D. P., Goldgar, D. E., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11385 · Cited by 52
Treatment of advanced male breast cancer
Kraybill, W. G., Kaufman, R. J., & Kinne, D. W. (1981) · Cancer · Cited by 51
Estrogen receptors in male breast cancer
Gupta, N. K., Cohen, J. L., Rosenbaum, C., & Raam, S. (1980) · Cancer · Cited by 51
BRCA2 germ-line mutations in Spanish male breast cancer patients
Dı́ez, O., Cortés, J. M., Domènech, M., et al. (2000) · Annals of Oncology · doi:10.1023/a:1008339009528 · Cited by 50
Orr, N., Cooke, R., Jones, M. E., Fletcher, O., Dudbridge, F., Chilcott-Burns, S., Tomczyk, K., Broderick, P., Houlston, R. S., Ashworth, A., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002290 · Cited by 47
Tamoxifen in the treatment of male breast carcinoma
Ribeiro, G. G. (1983) · Clinical Radiology · doi:10.1016/s0009-9260(83)80408-5 · Cited by 44
Fulvestrant and male breast cancer: a pooled analysis
Zagouri, F., Sergentanis, T. Ν., Chrysikos, D., Dimopoulos, M. A., & Ψαλτοπούλου, Θ. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3240-z · Cited by 43
A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up
Walshe, J. M., Berman, A. W., Vatas, U., Steinberg, S. M., Anderson, W. F., Lippman, M. E., & Swain, S. M. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9363-0 · Cited by 42
Leone, J. P., Leone, J., Zwenger, A. O., Iturbe, J., Leone, B. A., & Vallejo, C. T. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.10.038 · Cited by 42
Doebar, S. C., Slaets, L., Cardoso, F., Giordano, S. H., Bartlett, J. M. S., Tryfonidis, K., Dijkstra, N., Schröder, C. P., van Asperen, C. J., Linderholm, B. K., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.229 · Cited by 39
Self-citationPrognostic Variables in Male Breast Cancer
Clark, J. L., Nguyen, P., Jaszcz, W. B., Jatoi, A., & Niehans, G. A. (2000) · The American Surgeon · doi:10.1177/000313480006600515 · Cited by 38
Fogh, S. E., Kachnic, L. A., Goldberg, S. I., Taghian, A. G., Powell, S. N., & Hirsch, A. E. (2013) · Clinical Breast Cancer · doi:10.1016/j.clbc.2013.05.004 · Cited by 37
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer
Lauro, L. D., Vici, P., Medico, P. D., Laudadio, L., Tomao, S., Giannarelli, D., Pizzuti, L., Sergi, D., Barba, M., & Maugeri‐Saccà, M. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2675-y · Cited by 35
Male breast cancer: An 11 year review of 66 patients
McLachlan, S., Erlichman, C., Liu, F., et al. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806810 · Cited by 33
Little, M. P., & McElvenny, D. M. (2016) · Environmental Health Perspectives · doi:10.1289/ehp151 · Cited by 33
The Differences between Male and Female Breast Cancer
Omene, C. O., & Tiersten, A. (2010) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-374271-1.00042-3 · Cited by 32
CARCINOMA OF THE MALE BREAST: A REVIEW AND RECOMMENDATIONS FOR MANAGEMENT
Carmalt, H. L., Mann, L. J., Kennedy, C. W., Fletcher, J. M., & Gillett, D. J. (1998) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1998.tb04657.x · Cited by 29
CHEK2 1100delC is present in familial breast cancer cases of the Basque Country
Martínez-Bouzas, C., Beristain, E., Guerra, I., Gorostiaga, J. M., Mendizabal‐Zubiaga, J., De-Pablo, J.-L., García-Alegría, E., Sanz-Parra, A., & Tejada, M. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9351-4 · Cited by 29
Breast Cancer in Men-Should Aromatase Inhibitors Become First-Line Hormonal Treatment?
Nordman, I. C., & Dalley, D. N. (2008) · The Breast Journal · doi:10.1111/j.1524-4741.2008.00648.x · Cited by 29
Lauro, L. D., Vici, P., Barba, M., Pizzuti, L., Sergi, D., Rinaldi, M., Benedetto, A. D., Sperduti, I., Shaaban, A. M., Speirs, V., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3138-9 · Cited by 25
Cancer of the male breast: a review.
Williams, W. L., Powers, M. M., & Wagman, L. D. (1996) · PubMed · Cited by 23
The role of androgen receptor gene mutations in male breast carcinoma
Hiort, O., Naber, S. P., Lehners, A., Muletta-Feurer, S., Sinnecker, G. H. G., Zollner, A. N., & Komminoth, P. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784104 · Cited by 20
Russo, J., & Russo, I. H. (2004) · Springer eBooks · doi:10.1007/978-3-642-18736-0_5 · Cited by 9
Cited by
Łukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanisławek, A. (2021) · Cancers · doi:10.3390/cancers13174287 · Cited by 1,960
Loibl, S., Poortmans, P., Morrow, M., Denkert, C., & Curigliano, G. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32381-3 · Cited by 1,648
Li, N., Deng, Y., Zhou, L., Tian, T., Yang, S., Wu, Y., Zheng, Y., Zhai, Z., Hao, Q., Song, D., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0828-0 · Cited by 462
Epidemiology of male breast cancer
Konduri, S., Singh, M., Bobustuc, G., Rovin, R., & Kassam, A. (2020) · The Breast · doi:10.1016/j.breast.2020.08.010 · Cited by 411
Almansour, N. M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.836417 · Cited by 397
Metadata
- Authors
- Giordano, S. H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-06-14
- Volume
- 378
- Issue
- 24
- Pages
- 2311-2320
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2808444757
- Cited by
- 390
- References
- 99
- FWCI
- 28.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.